0000912061-19-000085.txt : 20191223 0000912061-19-000085.hdr.sgml : 20191223 20191223172329 ACCESSION NUMBER: 0000912061-19-000085 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20191219 ITEM INFORMATION: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20191223 DATE AS OF CHANGE: 20191223 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NATURAL HEALTH TRENDS CORP CENTRAL INDEX KEY: 0000912061 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-MISCELLANEOUS NONDURABLE GOODS [5190] IRS NUMBER: 592705336 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36849 FILM NUMBER: 191307236 BUSINESS ADDRESS: STREET 1: UNITS 1205-07, 12F, MIRA PLACE TOWER A STREET 2: 132 NATHAN ROAD, TSIMSHATSUI, KOWLOON CITY: HONG KONG STATE: K3 ZIP: 00000 BUSINESS PHONE: 852-3107-0800 MAIL ADDRESS: STREET 1: UNITS 1205-07, 12F, MIRA PLACE TOWER A STREET 2: 132 NATHAN ROAD, TSIMSHATSUI, KOWLOON CITY: HONG KONG STATE: K3 ZIP: 00000 8-K 1 a8-k12x19x2019.htm 8-K Document
false--12-310000912061 0000912061 2019-12-19 2019-12-19


UNITED STATES
 SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
 
 
December 19, 2019
 
Date of Report (Date of earliest event reported)
 
 NATURAL HEALTH TRENDS CORP.
(Exact name of registrant as specified in its charter)
Delaware
001-36849
59-2705336
(State or other jurisdiction of incorporation)        
(Commission File Number)  
(IRS Employer Identification No.)
 
 
 

 Units 1205-07, 12F, Mira Place Tower A, 132 Nathan Road, Tsimshatsui, Kowloon, Hong Kong
(Address of principal executive offices, including zip code)

+852-3107-0800
(Registrant’s telephone number, including area code)



Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
 Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Exchange Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, par value $0.001 per share
NHTC
The NASDAQ Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

   Emerging growth company

o   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.








Item 5.03
Amendment to Articles of Incorporation or Bylaws; Change in Fiscal Year.

Natural Health Trends Corp. (the “Company”) notes that the Delaware Chancery Court ‎ issued an opinion in In re VAALCO Energy, Inc. Stockholder Litigation invalidating as a ‎matter of law provisions of the certificate of incorporation and bylaws of VAALCO Energy, ‎Inc., a Delaware corporation, that permitted the removal of VAALCO’s directors by its ‎stockholders only for cause. The Chancery Court held that, in the absence of a classified board ‎or cumulative voting, VAALCO’s “only-for-cause” director removal provisions conflicted with ‎Section 141(k) of the Delaware General Corporation Law (“DGCL”) and were therefore invalid. ‎The Company further notes that the Chancery Court issued an opinion in Frechter v. Zier ‎invalidating a provision of a Delaware corporation’s bylaws that required a supermajority ‎stockholder vote to remove directors. The Chancery Court held that the supermajority bylaw ‎provision was invalid because it conflicted with Section 141(k) of the DGCL, which provides ‎that a director may be removed by vote of a simple majority of the shares then entitled to vote at ‎an election of directors.
Section 8 of the Certificate of Incorporation (the “Charter”) and Section 3.4 of the ‎Amended and Restated Bylaws (the “Bylaws”) of the Company contain “only-for-cause” ‎director removal provisions that require a supermajority vote, and the Company does not have a ‎classified board of directors or cumulative voting. As such, and in light of the foregoing ‎decisions of the Chancery Court, effective December 19, 2019, the Company’s Board of Directors amended Section 3.4 of ‎its Bylaws to provide that any director may be removed, with or without cause, with the required vote of the holders of shares then entitled to vote at an election of directors. Further, the Company will ‎not attempt to enforce the director removal provision contained in its Charter to the extent not in compliance with the DGCL, and the Board of Directors will recommend at the ‎Company’s 2020 annual meeting of stockholders that the Charter be amended to be compliant ‎with the terms of the DGCL.‎

The foregoing summary of the Bylaws amendment does not purport to be complete and is qualified in its entirety by reference to the First Amendment to the Amended and Restated Bylaws, a copy of which is filed as Exhibit 3.1.

Item 9.01    Financial Statements and Exhibits.

(d)    Exhibits









SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: December 23, 2019

 
NATURAL HEALTH TRENDS CORP.
 
 
 
 
 
 
 
 
 
By:
/s/ Timothy S. Davidson
 
 
 
Timothy S. Davidson
 
 
 
Senior Vice President and Chief Financial Officer
 






EXHIBIT INDEX




EX-3.1 2 ex31.htm EXHIBIT 3.1 Exhibit
EXHIBIT 3.1

FIRST AMENDMENT TO THE
AMENDED AND RESTATED
BYLAWS
OF
NATURAL HEALTH TRENDS CO.


In accordance with resolutions duly adopted and effective as of December 19, 2019 by the Board of Directors of Natural Health Trends Co. (the “Company”), Section 3.4 of the Company’s Amended and Restated Bylaws is hereby deleted and replaced in its entirety to read as follows:
“3.4‎    Removal of Directors. At any meeting of stockholders called expressly for ‎the purpose of removing a director or directors, any director or the entire Board of ‎Directors may be removed, with or without cause, with the required vote of the holders of shares then entitled to vote at an election of directors.‎”




EX-101.SCH 3 nhtc-20191219.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001000 - Document - Cover page link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 4 nhtc-20191219_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 5 nhtc-20191219_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 6 nhtc-20191219_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Cover page. Document Type Document Type Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, Address Line Three Entity Address, City or Town Entity Address, City or Town Entity Address, Country Entity Address, Country City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre-commencement Tender Offer Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security Title of 12(b) Security Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Emerging Growth Company Entity Emerging Growth Company Entity Central Index Key Entity Central Index Key Amendment Flag Amendment Flag Current Fiscal Year End Date Current Fiscal Year End Date EX-101.PRE 7 nhtc-20191219_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ZIP 8 0000912061-19-000085-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000912061-19-000085-xbrl.zip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end XML 9 FilingSummary.xml IDEA: XBRL DOCUMENT 3.19.3.a.u2 html 1 97 1 false 0 0 false 0 false false R1.htm 0001000 - Document - Cover page Sheet http://www.naturalhealthtrendscorp.com/role/CoverPage Cover page Cover 1 false false All Reports Book All Reports a8-k12x19x2019.htm ex31.htm nhtc-20191219.xsd nhtc-20191219_cal.xml nhtc-20191219_def.xml nhtc-20191219_lab.xml nhtc-20191219_pre.xml http://xbrl.sec.gov/dei/2019-01-31 true true XML 10 R1.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Cover page
Dec. 19, 2019
Cover page.  
Document Type 8-K
Document Period End Date Dec. 19, 2019
Entity Registrant Name NATURAL HEALTH TRENDS CORP.
Entity Incorporation, State or Country Code DE
Entity File Number 001-36849
Entity Tax Identification Number 59-2705336
Entity Address, Address Line One Units 1205-07, 12F
Entity Address, Address Line Two Mira Place Tower A
Entity Address, Address Line Three 132 Nathan Road
Entity Address, City or Town Tsimshatsui
Entity Address, Country HK
City Area Code 852
Local Phone Number 3107-0800
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.001 per share
Trading Symbol NHTC
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Entity Central Index Key 0000912061
Amendment Flag false
Current Fiscal Year End Date --12-31
JSON 12 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "a8-k12x19x2019.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "calculationLink": { "local": [ "nhtc-20191219_cal.xml" ] }, "definitionLink": { "local": [ "nhtc-20191219_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml", "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml" ] }, "inline": { "local": [ "a8-k12x19x2019.htm" ] }, "labelLink": { "local": [ "nhtc-20191219_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "nhtc-20191219_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "nhtc-20191219.xsd" ], "remote": [ "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd", "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd", "http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd", "http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd", "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd", "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 25, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2019-01-31": 3, "total": 3 }, "keyCustom": 0, "keyStandard": 97, "memberCustom": 0, "memberStandard": 0, "nsprefix": "nhtc", "nsuri": "http://www.naturalhealthtrendscorp.com/20191219", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "a8-k12x19x2019.htm", "contextRef": "D2019Q4DEC19", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001000 - Document - Cover page", "role": "http://www.naturalhealthtrendscorp.com/role/CoverPage", "shortName": "Cover page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "a8-k12x19x2019.htm", "contextRef": "D2019Q4DEC19", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cover page.", "label": "Cover page." } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three", "terseLabel": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country", "terseLabel": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "countryCodeItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } XML 13 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 15 a8-k12x19x2019_htm.xml IDEA: XBRL DOCUMENT 0000912061 2019-12-19 2019-12-19 false --12-31 0000912061 8-K 2019-12-19 NATURAL HEALTH TRENDS CORP. DE 001-36849 59-2705336 Units 1205-07, 12F Mira Place Tower A 132 Nathan Road Tsimshatsui HK 852 3107-0800 false false false false Common Stock, par value $0.001 per share NHTC NASDAQ false XML 16 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } EXCEL 17 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end